Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 5/2012

01-10-2012 | Editorial

ICJP and research and publication integrity

Author: J. W. Foppe van Mil

Published in: International Journal of Clinical Pharmacy | Issue 5/2012

Login to get access

Excerpt

In 2010, the 2nd World Conference on Research Integrity was held in Singapore. This Congress resulted in two declarations concerning the practice of scientific publication (an Authors’ declaration and an Editors declaration), which more or less confirm existing practice and to which the International Journal of Clinical Pharmacy also adheres. …
Literature
1.
Wager E, Kleinert S. Responsible research publication: International standards for authors. A position statement developed at the 2nd World Conference on Research Integrity, Singapore, July 22–24, 2010. Chapter 50 In: Mayer T, Steneck N editors. Promoting Research Integrity in a Global Environment. Singapore: Imperial College Press/World Scientific Publishing; 2011. p. 309–316. (ISBN 978-981-4340-97-7).
2.
Kleinert S, Wager E. Responsible research publication: international standards for editors. A position statement developed at the 2nd World Conference on Research Integrity, Singapore, July 22–24, 2010. Chapter 51 In: Mayer T, Steneck N editors. Promoting Research Integrity in a Global Environment. Singapore: Imperial College Press/World Scientific Publishing; 2011. p. 317–28. (ISBN 978-981-4340-97-7).
3.
International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical Journals: Ethical considerations in the conduct and reporting of research: authorship and contributorship. 2009. [Cited 27 July 2012]. Available from: http://​www.​icmje.​org/​ethical_​1author.​html.
4.
Metadata
Title
ICJP and research and publication integrity
Author
J. W. Foppe van Mil
Publication date
01-10-2012
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2012
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9695-2

Other articles of this Issue 5/2012

International Journal of Clinical Pharmacy 5/2012 Go to the issue

Retraction Note

Retraction Note: Use of antidepressants and the risk of type 2 diabetes mellitus: a nested case–control study

Research Article

Drug use before and during pregnancy in Serbia

Research Article

Difference of antihypertensive prescribing between office- and hospital-based clinics in Taiwan

Case Report

Overdose of pegfilgrastim: case report

Research Article

Cost effectiveness of three drugs for the treatment of S. aureus infections in Nigeria

Research Article

The influence of consumers’ preferences and perceptions of oral solid dosage forms on their treatment
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits